Yüklüyor......
PHARMACOTHERAPY FOR RHEUMATOID ARTHRITIS IN THE 21st CENTURY: FOCUS ON RITUXIMAB
Rheumatoid arthritis (RA) is one of the most common and severe chronic inflammatory diseases. The paper reviews the recent studies evaluating the efficacy of rituximab (MabThera®), chimeric anti-CD20 monoclonal antibodies in B cells, in patients with RA. It has been shown that Rituximab is an extrem...
Kaydedildi:
| Yazar: | |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Russo |
| Baskı/Yayın Bilgisi: |
IMA-PRESS LLC
2009-12-01
|
| Seri Bilgileri: | Современная ревматология |
| Konular: | |
| Online Erişim: | https://mrj.ima-press.net/mrj/article/view/261 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|